SOX8 and ovarian cancer: To determine the clinical significance of Aurora-A, SOX8, and FOXK1 in ovarian cancer, we assessed their expression patterns using cisplatin-sensitive and -resistant ovarian cancer tissue microarrays (n = 246 and 185, respectively).